根据中国药典2020、ICH、OECD、ISO 17025和许多其他全球公认的标准，伯朗氏的研究者团队、设施和经验丰富的实验室管理可以提供高质量的工作。

包括：

ICH Q8（R2）Pharmaceutical Development (Aug 2009)

ICH Q9 Quality Risk Management (Nov 2005)

FDA Guidance for Industry：Container Closure Systems for Packaging Human Drugs and Biologics  （May 1999）

FDA Guidance to Industry：Metered Dose Inhaler (MDI)and Dry Powder Inhaler (DPI) Drug Product (Nov 1998) 

FDA Guidance for Industry: Nasal Spray and Inhalation Solution, Suspension, and Spray Drug Products (July  2002)

欧盟：Guideline on plastic immediate packaging materials（2005）

PQRI Recommendation, Safety Thresholds and Best Practices for E/L in Orally Inhaled and Nasal Drug Products (Sep 2006)

ISO  8871-2：2004  Elastomeric  Parts for Paternal and for Devices for Pharmaceutical Use

USP General Chapter <381> Elastomeric  Closures for Injections

USP General Chapter <661> Containers—Plastics

USP General Chapter <1660> Evaluation of the Inner Surface Durability of Glass Contaniers

USP General Chapter <1663> Assessment of Extractables Associated with Pharmaceutical Packaging/Delivery Systems.

USP General Chapter <1664> Assessment of Drug Product Leachables Associated with Pharmaceutical Packaging Delivery Systems

EP Chapter 2.9.17 Test  for extractable Volume of paternal preparations

European Pharmacopeia (EP) Testing

        3.1 Series; Materials Used for the Manufacture of Containers

        3.2 Series; Containers

中国药典2020版四部9621，9622

YBB00142002-2015药品包装材料与药物相容性试验指导原则

化学药品注射剂与塑料包材相容性技术指导原则 （2012）

化学药品注射剂与药用玻璃包装容器相容性研究技术指导原则（试行）（2015）

化学药品与弹性体密封件相容性研究技术指导原则（试行 2018-04-26）